available for iOS, Android and web
June 28, 2012
Medication shortages in the US appear to be a direct result of "over-aggressive and excessive regulatory action," say legislators, who accuse the Food and Drug Administration (FDA) of "failing to ensure the availability of quality products."
June 20, 2011
During 2003-10, the US FDA approved more new cancer drugs, and did it faster, than the EMA, and the drugs approved by both agencies got to US patients more quickly than to Europeans, says a new study.
PharmaTimes 2014 Copyright | RSS Feed Subscriptions